Sanofi Income from Discontinued Operations 2012-2026 | SNY

Sanofi income from discontinued operations for the twelve months ending March 31, 2026 was $3.099B, a 1590.46% increase year-over-year.

  • Sanofi annual income from discontinued operations for 2025 was $3.252B, a 4595.24% increase from 2024.
  • Sanofi annual income from discontinued operations for 2024 was $0.069B, a 0% decline from 2023.
  • Sanofi annual income from discontinued operations for 2023 was $0B, a 0% decline from 2022.

Sanofi Income from Discontinued Operations 2012-2026 | SNY

  • Sanofi annual income from discontinued operations for 2025 was $3.252B, a 4595.24% increase from 2024.
  • Sanofi annual income from discontinued operations for 2024 was $0.069B, a 0% decline from 2023.
  • Sanofi annual income from discontinued operations for 2023 was $0B, a 0% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B